News|Articles|June 15, 2021
Process Development Improvements Post-Pandemic
Author(s)Pharmaceutical Technology Editors
What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?
Advertisement
In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Shaping the Future of Microbial Development: From Gene to GMP
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
WEF Welcomes ACG Shirwal as First Pharma Packaging Site in Global Lighthouse Network
4
Rare Disease Treatments: Navigating the Economics of Global Innovation
5